Download now
← Case studies
2022-07-26Regulations

Pharmaceutical Company Transitions to CSA Model with USDM Expertise

Learn how USDM helped a pharmaceutical company achieve greater efficiencies in their validation process through a hybrid CSA model for testing.

Learn how USDM helped a pharmaceutical company achieve greater efficiencies in their validation process through a hybrid CSA model for testing

USDM worked in collaboration with a large pharmaceutical company to help update its internal validation processes. This enhanced the efficiencies of the company’s testing activities. With USDM’s expertise and assistance, the company moved away from a CSV model to a new hybrid CSA model.

The Situation
  • A pharmaceutical company focused on research, development, and manufacturing-focused primarily in dermatology, oncology, and specialty injectable therapeutic areas
  • The company had a cumbersome CSV process in place for validation
  • Their validation processes were time-consuming and required an excessive amount of documentation
The Solution
  • USDM worked in partnership with the company’s internal team to re-work their entire validation structure
  • USDM moved the company’s internal processes from a traditional computer system validation (CSV) to a hybrid computer system assurance (CSA) process
  • USDM helped the company to recreate internal SOPs and templates to gain efficiencies

The Results

  • The company significantly reduced the number of scripted tests in their validation processes
  • They reduced the amount of time spent documenting procedures, allowing more time for critical testing
  • USDM created comprehensive, standardized procedures for the customers’ testing activities and helped train internal teams

Testimonial

“USDM provided a great framework for re-aligning our cumbersome CSV process to adopt the CSA methodology.  Their experience and insight on this true risk-based approach really helped shift mindsets from documentation-focused to testing-focused. The draft procedures and tools they collaborated with us on are now the basis for CSV at our company.” – Process & Project Development Engineer

Download our datasheet to continue learning about CSA.

Start here

Put AI to work in life sciences — with the right guardrails underneath.

Start with a structured AI Readiness Assessment: fixed-fee, executive-ready, and built to surface the highest-value workflows first.

  • Workflow inventory and risk classification
  • Business value and readiness scoring
  • FDA CSA + EU AI Act + ISO 42001 gap analysis
  • Prioritized 90-day roadmap by impact, risk, and effort

Start here

Talk to USDM

Tell us what workflow or outcome you want to improve and we'll map the right AI, governance, and delivery path.

By submitting this form, you agree to USDM’s Privacy Policy and consent to receive communications from USDM. You can unsubscribe at any time using the link in our emails.